TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RARE

Ultragenyx

Healthcare · Biotechnology

14.50$ -1.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Ultragenyx (RARE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 673 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RARE
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – 0.0 0.0 0.1 2.6 51 104 271 351 363 434 560 673
– – – 0.0 1.4 183 0.0 1.1 9.0 6.1 16 28 45 77 109
– – – 0.0 -1.4 0.1 2.6 50 95 265 335 335 389 484 564
4.7 13 28 46 115 183 232 294 357 412 497 706 648 698 750
1.8 3.3 4.5 11 33 65 100 128 162 183 220 278 310 322 349
6.6 16 32 57 148 248 332 422 519 595 717 984 958 1,019 1,099
-6.6 -16 -32 -57 -148 -248 -329 -371 -424 -330 -382 -649 -569 -536 -535
0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 33 29 43 66 63 62
-6.8 -16 -35 -60 -146 -246 -318 -197 -399 -185 -453 -702 -608 -568 -571
0.2 -0.4 -3.0 -0.7 -2.3 0.0 -16 0.5 3.3 1.2 1.0 5.7 -1.8 1.6 4.0
-6.8 -16 -35 -60 -146 -246 -302 -198 -403 -187 -454 -707 -607 -569 -575
-6.5 -16 -35 -56 -146 -245 -323 -178 -390 -140 -410 -640 -516 -469 -474

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?